Detalhe da pesquisa
1.
Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare.
Am J Hum Genet
; 110(3): 419-426, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868206
2.
From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient views.
Oncologist
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713191
3.
ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue.
Future Oncol
; 20(7): 361-371, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37767626
4.
Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.
Int J Cancer
; 153(7): 1413-1422, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37424386
5.
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations.
Br J Cancer
; 129(3): 475-485, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365284
6.
Psychological predictors of advanced cancer patients' preferences for return of results from comprehensive tumor genomic profiling.
Am J Med Genet A
; 188(3): 725-734, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34755933
7.
Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study.
Support Care Cancer
; 30(10): 8201-8210, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35809119
8.
Germline RET variants underlie a subset of paediatric osteosarcoma.
J Med Genet
; 58(1): 20-24, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32179705
9.
Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study.
J Genet Couns
; 31(1): 96-108, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34218500
10.
Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling.
Int J Technol Assess Health Care
; 38(1): e57, 2022 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674123
11.
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
Cancer
; 127(16): 2934-2942, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33910263
12.
Optical mapping reveals a higher level of genomic architecture of chained fusions in cancer.
Genome Res
; 28(5): 726-738, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29618486
13.
Germline PALB2 Variants and PARP Inhibitors in Endometrial Cancer.
J Natl Compr Canc Netw
; 19(11): 1212-1217, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781271
14.
Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling.
Psychooncology
; 30(11): 1920-1929, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34240516
15.
Fear of cancer recurrence in patients undergoing germline genome sequencing.
Support Care Cancer
; 29(12): 7289-7297, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34036439
16.
Cancer patients' views and understanding of genome sequencing: a qualitative study.
J Med Genet
; 57(10): 671-676, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31980566
17.
Influence of lived experience on risk perception among women who received a breast cancer polygenic risk score: 'Another piece of the pie'.
J Genet Couns
; 30(3): 849-860, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33470033
18.
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.
Lancet
; 394(10197): 478-487, 2019 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31229240
19.
Who should access germline genome sequencing? A mixed methods study of patient views.
Clin Genet
; 97(2): 329-337, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31674008
20.
Translating genomic risk into an early detection strategy for sarcoma.
Genes Chromosomes Cancer
; 58(2): 130-136, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30382615